10 days ago
Hyderābād, IndiaSenior
Responsibilities
- Develop, enhance, debug, and support ABAP solutions in SAP S/4HANA for OTC and PTS processes.
- Build enhancements for sales orders, delivery, billing, pricing, and tax-related functionality.
- Develop and enhance interfaces using IDocs, RFCs, BAPIs, and OData.
- Perform debugging, performance tuning, testing support, and production issue resolution.
- Collaborate with architects, functional, logistics, compliance, integration, and business teams on technical solutions.
- Provide technical leadership and mentor junior developers on SAP engineering practices.
Requirements
- Doctorate degree, or a master's degree in computer science or a STEM major plus 5–7 years of IT or related experience.
- Alternatively, a bachelor's degree in computer science or a STEM major plus 7–10 years of IT or related experience, or a computer science/STEM diploma plus 11–14 years of IT or related experience.
- Strong ABAP development and support experience in SAP S/4HANA, particularly in OTC and PTS processes.
- Experience with IDocs, RFCs, BAPIs, OData, debugging, performance tuning, testing, and production support.
- Ability to collaborate across functional, integration, business, compliance, and SAP consulting teams in a regulated environment.
- SAP Certified Development Associate – ABAP with SAP NetWeaver certification is listed; SAP Certified Development Associate – ABAP for SAP S/4HANA is preferred.
- Strong communication, problem-solving, documentation, collaboration, and attention-to-detail skills.
Tech Stack
ABAP
Categories
About Amgen
Amgen is a public biotechnology company that discovers, develops, manufactures, and sells biologic and biosimilar therapeutics for patients with serious diseases. Its portfolio and pipeline span oncology, cardiovascular disease, osteoporosis, inflammation, and rare diseases, marketed globally through direct sales and partnerships. Founded in 1980 and headquartered in Thousand Oaks, California (NASDAQ: AMGN), Amgen is a component of the Dow Jones Industrial Average and completed the acquisition of Horizon Therapeutics in 2023.